Chlorosomes of green sulfur bacteria: Pigment composition and energy transfer

Autor: Jan Amesz, van Noort Pi, Thijs J. Aartsma, Stephan C.M. Otte, Schoumans N, Christof Francke

Publikováno v: Photosynthesis Research. 41:193-203

The pigment composition and energy transfer pathways in isolated chlorosomes ofChlorobium phaeovibrioides andChlorobium vibrioforme were studied by means of high performance liquid chromatography (HPLC) and picosecond absorbance difference spectrosco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fdc62aa3609440ba699f8df2fe8cf23
https://doi.org/10.1007/bf02184160

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2 .

Autor: van Kampen JGM; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., van Hooij O; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., Jansen CF; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., Smit FP; MDxHealth B.V., Nijmegen, the Netherlands., van Noort PI; InteRNA Technologies B.V., Utrecht, the Netherlands., Schultz I; InteRNA Technologies B.V., Utrecht, the Netherlands., Schaapveld RQJ; InteRNA Technologies B.V., Utrecht, the Netherlands., Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands., Verhaegh GW; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud university medical center, Nijmegen, the Netherlands. Gerald.Verhaegh@radboudumc.nl.

Publikováno v: Cancer research [Cancer Res] 2017 Apr 15; Vol. 77 (8), pp. 2008-2017. Date of Electronic Publication: 2017 Feb 16.

Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma.

Autor: Babae N; Utrecht Institute for Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands. These authors contributed equally to this work., Bourajjaj M; InteRNA Technologies B.V., Utrecht, the Netherlands. These authors contributed equally to this work., Liu Y; Aparna Biosciences Corporation, Rockville MD, USA. These authors contributed equally to this work., Van Beijnum JR; VU University Medical Center, MB Amsterdam, the Netherlands., Cerisoli F; InteRNA Technologies B.V., Utrecht, the Netherlands., Scaria PV; Aparna Biosciences Corporation, Rockville MD, USA., Verheul M; InteRNA Technologies B.V., Utrecht, the Netherlands., Van Berkel MP; VU University Medical Center, MB Amsterdam, the Netherlands., Pieters EH; Utrecht Institute for Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands. ., Van Haastert RJ; InteRNA Technologies B.V., Utrecht, the Netherlands., Yousefi A; Utrecht Institute for Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands. ., Mastrobattista E; Utrecht Institute for Pharmaceutical Sciences, University Utrecht, Utrecht, the Netherlands. ., Storm G; MIRA Institute for Biomedical Technology & Technical Medicine, Faculty of Science & Technology, University of Twente, AE Enschede, the Netherlands., Berezikov E; Hubrecht Institute, Cancer Genomics Center and University Medical Center Utrecht, Utrecht, the Netherlands., Cuppen E; Hubrecht Institute, Cancer Genomics Center and University Medical Center Utrecht, Utrecht, the Netherlands., Woodle M; Aparna Biosciences Corporation, Rockville MD, USA., Schaapveld RQ; InteRNA Technologies B.V., Utrecht, the Netherlands., Prevost GP; InteRNA Technologies B.V., Utrecht, the Netherlands., Griffioen AW; VU University Medical Center, MB Amsterdam, the Netherlands., Van Noort PI; InteRNA Technologies B.V., Utrecht, the Netherlands., Schiffelers RM; Laboratory Clinical Chemistry & Haematology, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands.

Publikováno v: Oncotarget [Oncotarget] 2014 Aug 30; Vol. 5 (16), pp. 6687-700.

A functional screen identifies specific microRNAs capable of inhibiting human melanoma cell viability.

Autor: Poell JB; Hubrecht Institute, University Medical Center Utrecht, Cancer Genomics Center, Utrecht, The Netherlands., van Haastert RJ, de Gunst T, Schultz IJ, Gommans WM, Verheul M, Cerisoli F, van Puijenbroek AAFL, van Noort PI, Prevost GP, Schaapveld RQ, Cuppen E

Publikováno v: PloS one [PLoS One] 2012; Vol. 7 (8), pp. e43569. Date of Electronic Publication: 2012 Aug 22.